Position in NGEN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$73,130
-$6,040 QoQ
Shares Held
35,500
+69.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 62 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GREAT VALLEY ADVISOR GROUP, INC. holds $5,771,539 across 13 Biotechnology names. NGEN ranks #11 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,947 | $2,734,138 | |
| 2 | CELC |
Celcuity Inc.
|
5,591 | $584,930 | |
| 3 | INCY |
Incyte Corp
|
5,040 | $571,334 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
874 | $434,142 | |
| 5 | SMMT |
Summit Therapeutics Inc.
|
25,840 | $376,488 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,080 | $260,247 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
379 | $236,321 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
2,700 | $201,096 |
All Filings in NGEN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,130 | 35,500 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $79,170 | 21,000 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||